MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-13-2026
Exact Sciences Corporation Operating Expenses 2011-2026 | EXAS
Annual Operating Expenses Exact Sciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.47 B | 2.98 B | 2.06 B | 2 B | - | - | 893 M | 496 M | 305 M | 223 M | 174 M | 98 M | 50.9 M | 56.8 M | 33 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.98 B | 33 M | 910 M |
Quarterly Operating Expenses Exact Sciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 609 M | 565 M | 597 M | - | 534 M | 518 M | 553 M | - | - | - | - | - | - | - | - | 555 M | 481 M | 471 M | 572 M | 761 M | 496 M | 237 M | 328 M | 309 M | 202 M | 182 M | 187 M | - | 129 M | 109 M | 104 M | - | 80.3 M | 71.1 M | 66.9 M | - | 54.2 M | 56.2 M | 53.7 M | - | 48.4 M | 42.4 M | 36.1 M | - | 31.3 M | 19.6 M | 16.5 M | - | 12.3 M | 13.4 M | 11.9 M | - | 14 M | 15.9 M | 11.7 M | - | 8.88 M | 7.68 M | 5.44 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 761 M | 5.44 M | 219 M |
Operating Expenses of other stocks in the Diagnostics research industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Anixa Biosciences
ANIX
|
9.98 M | $ 2.89 | -2.36 % | $ 93.8 K |  USA |
 |
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
1.99 B | $ 118.67 | 0.46 % | $ 36.1 B | USA |
 |
Celcuity
CELC
|
113 M | $ 109.39 | 1.0 % | $ 4.32 B | USA |
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
59.5 M | $ 27.81 | -0.64 % | $ 772 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M |  Britain |
 |
Charles River Laboratories International
CRL
|
607 M | $ 177.9 | -0.41 % | $ 8.82 B | USA |
 |
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
181 M | $ 14.03 | -1.23 % | $ 424 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | USA |
|
Biodesix
BDSX
|
106 M | $ 15.96 | 1.3 % | $ 2.07 B | USA |
 |
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
41.3 M | $ 1.1 | -3.49 % | $ 1.4 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 208.55 | -0.82 % | $ 23.1 B | USA |
 |
Danaher Corporation
DHR
|
6.71 B | $ 202.93 | -1.44 % | $ 145 B | USA |
 |
Bioventus
BVS
|
217 M | $ 8.85 | 0.91 % | $ 554 M | USA |
 |
DarioHealth Corp.
DRIO
|
62.2 M | $ 10.5 | -2.33 % | $ 298 M |  Israel |
 |
DexCom
DXCM
|
1.89 B | $ 72.97 | -1.1 % | $ 28.5 B | USA |
 |
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B |  Niderland |
 |
Burning Rock Biotech Limited
BNR
|
726 M | $ 24.2 | -3.82 % | $ 254 M | China |
 |
CareDx, Inc
CDNA
|
411 M | $ 18.66 | -0.45 % | $ 994 M | USA |
 |
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
408 M | $ 108.73 | 0.42 % | $ 8.97 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.3 B | $ 635.4 | -0.2 % | $ 51.1 B | USA |
 |
Illumina
ILMN
|
3.69 B | $ 130.82 | -1.55 % | $ 20.8 B | USA |
 |
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M | Israel |
 |
Guardant Health
GH
|
226 M | $ 93.48 | 1.35 % | $ 11.7 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 283.3 | -1.03 % | $ 23.6 B | USA |
 |
IQVIA Holdings
IQV
|
2.94 B | $ 174.31 | 0.02 % | $ 30 B | USA |
 |
Lantheus Holdings
LNTH
|
123 M | $ 78.0 | 2.23 % | $ 5.26 B | USA |
 |
Brainsway Ltd.
BWAY
|
29.2 M | $ 23.0 | -2.91 % | $ 99.4 M | Israel |
 |
Co-Diagnostics
CODX
|
45.3 M | - | - | $ 79.8 M | USA |
 |
Mettler-Toledo International
MTD
|
1.01 B | $ 1 317.07 | -0.45 % | $ 27.1 B |  Schweiz |
 |
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | USA |
 |
Myriad Genetics
MYGN
|
964 M | $ 5.26 | 4.99 % | $ 487 M | USA |
 |
NeoGenomics
NEO
|
430 M | $ 9.5 | - | $ 1.22 B | USA |
 |
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
258 M | $ 208.69 | 4.26 % | $ 20.5 B | USA |
 |
Pacific Biosciences of California
PACB
|
600 M | $ 1.54 | -4.94 % | $ 462 M | USA |
 |
Neogen Corporation
NEOG
|
1.48 B | $ 11.01 | -1.3 % | $ 2.39 B | USA |
 |
Precipio
PRPO
|
13.6 M | $ 24.5 | -0.73 % | $ 31.8 M | USA |
 |
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | USA |